The analytical method used for the analysis of biological/biotechnological products is known as bioanalytical testing. Analytical techniques plays a vital role in biotechnology and pharmaceuticals manufacturing. Bioanalytical tests are used in drug discovery, drug development, as well as in the commercialization of drugs.
Market Dynamics:
Increase in burden of chronic diseases, high demand for novel therapeutics, increasing number of clinical trials and drug approvals, increasing preference for outsourcing analytical testing, and the outbreak of COVID-19 are major factors expected to drive growth of the global bioanalytical testing services market over the forecast period.
For instance, in June 2020, BioAgilytix, a global provider of contract bioanalytical testing services, announced that it is now offering customizable COVID-19 testing packages to address a breadth of sponsor and employer needs stemming from the COVID-19 pandemic. Furthermore, Triangle Laboratory, a leading bioanalytical testing laboratory specializing in ligand binding and cell-based assays, announced the bioanalytical service to COVID-19 related studies.
Key features of the study:
- This report provides in-depth analysis of the global bioanalytical testing services market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global bioanalytical testing services market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include PPD Inc., Icon Plc, Syneos Health, Laboratory Corporation of America Holdings, and Charles River Laboratories International Inc., among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global bioanalytical testing services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bioanalytical testing services market.
Detailed Segmentation:
- Global Bioanalytical Testing Services Market, By Method Type:
- Small Molecules
- Large Molecules
- Global Bioanalytical Testing Services Market, By Test Type:
- Bioavailability and Bioequivalence Studies
- Pharmacokinetics
- Pharmacodynamics
- Other Test Types
- Global Bioanalytical Testing Services Market, By Geography:
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
- Company Profiles:
- PPD Inc.
- Icon Plc
- Syneos Health
- Laboratory Corporation of America Holdings
- Charles River Laboratories International Inc.
Table of Content - Bioanalytical Testing Services Market
